1,632
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Endocrinological Mechanisms of Depressive Disorders and Ill Health

Stress is common, but reactions to stress vary greatly from person to person. Acute stresses are common and are a part of daily life. Mild, short-term acute stresses are adaptive and are also part of day-to-day life. Whereas, intense (severe, pathogenic) acute stresses that are associated with life-threatening situations, real or perceived, could lead to persistent behavioral and psychological abnormalities. Stress-induced symptomatology can be mistaken for other diseases.

If the intensity of the stressor exceeds adaptive capabilities of the individual, such stresses, can also result in stress-related disorders including anxiety and depression, as well as severe traumatic stress leading to post-traumatic stress disorder (PTSD). Unmanaged stress causes physical and mental strain, poor performance and lack of productivity,[Citation1] and can lead to harmful health outcomes, including obesity, type 2 diabetes and myocardial infarction.[Citation2]

Approximately half of people with PTSD also suffer from major depressive disorder.[Citation3] Overt mental strain also can lead to depression, inability to perform, difficulties in interpersonal relationships and PTSD. Accumulating evidence supports hormone-dependent mechanisms in many of these stress-related disorders. While the latter seems to be a general phenomenon including depression (which probably is the largest group of psychological disorders), this editorial focuses on PTSD as an example to illustrate the underlying endocrine abnormalities associated with severe stress.

What is stress?

Both acute and chronic stresses can be expressed as physical, emotional or psychological. Based on their duration, stresses can be classified as acute or chronic, but based on nature of the stressor these can be categorized into physical, psychoemotional, and so forth. Over-intensive psychoemotional stresses are commonly designated as ‘traumatic’; PTSD comes under this category. Unmanaged pathological stresses induces a cascade of sustained abnormalities, as in the case with PTSD.

Not only the coping abilities vary from person to person, but also stress is highly individual, and its effects vary depending on genetics, upbringing, experience, ethnicity and culture.[Citation2] Previous experience and exposure, such as intrauterine (mal)nutrition and the environment, school or workplace bullying, discrimination,[Citation4] abuse and neglect, and upbringing, influence how one handles and reacts to stressful situations.[Citation2,Citation5] Although many of these situations are beyond an individual’s control, learning to handle and minimize stress is essential for balancing life. Unmanaged chronic stress can also lead to many other diseases, including eating disorders, smoking, alcohol and drug abuse, behavioral issues and addiction.[Citation5]

Chronic stress and ill health

In evolutionary terms, the neurohormonal changes that occur during acute stress are expected to last only for a short period. However, intense acute stress or frequent sustained stresses over a long period cause the negative biochemical and neurohormonal changes to become persistent,[Citation2] these escalating stresses would lead to ‘restructuring’ of brain centers related to reasoning and behavior.[Citation6]

The adverse health issues of unmanaged stress and inappropriate or pathological responsiveness of the stress system affect and disrupt many bodily systems, including endocrine system; digestive system (stomachache, slow gastric emptying, enhanced colonic peristalsis leading to abdominal cramps and diarrhea); impairment of the immune system (frequent infections; chronic fatigue syndrome); changes in appetite and alteration of metabolism (weight gain or loss); cardiovascular dysfunction (hypertension, tachycardia, hyperlipidemia and hyperglycemia); nervous system manifestations (anxiety, depression, insomnia, lack of interest); and impaired memory.[Citation6Citation8]

Neurohormonal responses to stress

The most familiar acute stress response is the ‘fight or flight’ reaction. The stress response causes immediate release of the stress hormones cortisol and adrenalin, which intensify mental concentration and enhance rapid reactions; survival mechanisms.[Citation2] The associated neurohormonal secretions cause tachycardia and hypertension, and enhance immune responses and memory. These physiological systems have evolved to cope with day-to-day, short-term stresses and provide self-protection; however, the system is designed to return to baseline rapidly, after cessation of stress.

Human bodily systems are not designed to cope with chronic stresses.[Citation5] Whether stress is acute or chronic, the body responds through allostasis, achieving stability and homeostasis through physiological or behavioral changes.[Citation9,Citation10] Intense acute stresses or chronic stresses could lead to sustained excess (or under) production of stress hormones, which poses physiologic challenges. Persistent neurohormonal, biochemical and physiological abnormalities cause undesirable structural brain changes and several adverse health outcomes.[Citation5,Citation6]

Consequences of the inability to cope with stress

Feeling anxious, nervous, distracted and pressured are common when experiencing stress, but these feelings usually are transient. Additional signs and symptoms of stress include depression, fatigue, irritability, withdrawal, antisocial behavior, chest pain, dizziness, breathlessness, menstrual irregularities, erectile dysfunction and loss of libido.[Citation6] Although the majority of these are nonspecific, many including depression have an underlying etiology of disruption of endocrine system.[Citation11,Citation12]

Physiological ways we cope with stress

In most instances, stress-associated symptomatology is minor, transient, appropriate for the situation. These are relieved through previously learned coping skills, such as avoidance or methods used to diffuse stress, such as engaging in leisure activities, reading, exercising, music, relaxation or meditation.[Citation13,Citation14] However, stresses that are severe may lead to pathological status with various clinical manifestations that requires psychological or medical assistance.[Citation6]

Regular, moderate exercises improve physical and psychological health and brain function, including memory.[Citation5,Citation6,Citation15] The long-term effects of chronic stress can be reduced by minimizing oxidative stresses, such as eating a healthy diet and avoiding smoking and drinking too much alcohol. Most people need to be educated on how to cope with stresses rather than becoming dependent on prescription medications. Relaxation tools, such as meditation, exercise, Pilates, Tai Chi and yoga, should be used as complementary methods for overcoming stress.[Citation6,Citation14] Offering well-organized therapeutic plans to stressed individuals empower the “stressed” individuals, and enable them to overcome chronic stress and reverse the endocrinological abnormalities that impair their lifestyle and productivity.[Citation16] Proceeding sections examine the neurohormonal abnormalities in PTSD, as an example of a severe stress-related disorder.

Post-traumatic stress disorder

PTSD is defined as a severe anxiety disorder that develops after exposure to a stressful event with actual or perceived threat or danger to the physical integrity of oneself or another person.[Citation17] PTSD is a serious psychological abnormality that can affect military and civilian personnel.[Citation18Citation20] Depending on an individual’s personality and resilience, PTSD can occur after exceedingly stressful incidents or seemingly minor ones.

PTSD is a multisystem disorder with endocrine abnormalities. Combined and targeted treatments using conventional antipsychotic agents, hormone and analogs, and non-traditional methods such as meditation improve symptoms and can cure PTSD.[Citation6,Citation14] Multiple factors, including genetic susceptibility; past experiences; cultural, spiritual and personal beliefs; experiencing discrimination, bullying, and harassment; and lack of social support, increase the risks for the development of PTSD and its relapses.[Citation15,Citation21]

Biochemical and neurohormonal abnormalities in PTSD

After a major physical or psychological trauma, the conditioned fear response that is generated in the medial prefrontal cortex is inhibited.[Citation22] It alters the memory and initiates a disruption of the hypothalamic–pituitary–adrenal (HPA) axis.[Citation6] Similar to the responses in patients with acute medical or surgical illnesses, patients with PTSD have increased serum epinephrine and norepinephrine levels, pro-opiomelanocortin-derived peptides, thyroid hormones, in addition to other hormonal abnormalities [Citation2,Citation23] but having inappropriately low glucocorticoid levels.[Citation6,Citation24Citation26]

These sustained biochemical and hormonal abnormalities initiate and maintain PTSD. In addition, the associated pathophysiological neurohormonal changes instigate maladaptive learning processes.[Citation2,Citation5,Citation14] Inappropriately high levels of sustained anxiety and fear emerging through the impaired HPA axis lead to persistent elevation of circulatory norepinephrine and suboptimal circulatory glucocorticoid levels [Citation16,Citation27,Citation28] that does not respond to the day-to-day stresses and needs.

The noradrenergic neurons play a central role in coordinating the interaction of multiple cortical regions, which is an essential aspect of parallel distributed processing as well as reasoning, memory and behavior. Modifications of neural networks have a secondary effect of kindling in the hippocampus that further moderates the individual’s sensitivity to a range of stressors.[Citation29] These paradoxical abnormalities are not unique to PTSD but may exist with other psychiatric disorders including severe depressive disorders.[Citation5]

Chronic changes of these hormones [Citation27,Citation30] not only initiate functional defects but also structural brain changes impairing the ability of an individual to react to stress rationally.[Citation31] In addition, PTSD is associated with a hypothalamic corticotrophin releasing hormone (CRH) hyperdrive but with insensitivity of CRH receptors, and thus, adrenal glands will hypofunction.[Citation32] In healthy states, adrenal glands release glucocorticoids in a pulsatile manner depending on the physiological requirements.[Citation2] This too is disrupted in persons with PTSD. However, it is not clear whether simply they fail to respond to the needs, or develop a lower ‘set point’ (exaggerated desensitization of adrenocorticotropic hormone/CRH receptors) and continue to secrete at a lower rate throughout the day (i.e., altered chronobiology); either processes are physiologically inappropriate.

It has been reported that while PTSD subjects showed a greater circadian signal-to-noise ratio in circulatory stress hormones, depressed patients displayed a less-rhythmic, more chaotic pattern of cortisol release. The pattern of cortisol secretion in PTSD patients under baseline conditions may reflect an exaggerated receptor desensitization, whereas the chronobiologic alterations in depression may reflect dysregulation of the HPA axis.[Citation33] Whereas, overactivity of vasopressin and defective 5-hydroxytryptamine/5-HT1A has also been observed in these patients.[Citation16] These multiple hormonal and cytokine abnormalities initiate a cascade of neurohormonal secretion and receptor abnormalities, leading to sustained symptomatology.[Citation7,Citation8,Citation11,Citation12,Citation16,Citation28]

Conclusions

Data support that neuroendocrine abnormalities attributed to PTSD include HPA hyper-reactivity and desensitized glucocorticoid feedback.[Citation26] Resulting inconsistent hormonal pattern represents a key pathological maladaptation to stress.[Citation6] These abnormal hormonal, metabolic responses and mitochondrial, biochemical, and neurohormonal abnormalities lead to structural brain vicissitudes occurring in the amygdala and hippocampus, locus coeruleus, and autonomic norepinephrine centers in the brainstem, which further alters behavioral responses.[Citation2,Citation6,Citation23]

The development of the symptoms of PTSD can be explained by disturbances of parallel distributed processing of neural pathways. Moreover, the disturbances of noradrenergic neurons in PTSD are likely to manifest as a dysfunctional modulation of working memory and involuntary traumatic recollection and flashback.[Citation29] Meanwhile, comorbidity in major depressive disorders and PTSD reflects not only overlapping symptoms in the two disorders, but also the co-occurrence of biological correlates and trauma-related phenotypes.[Citation3] While there are some similarities of presentation and biochemical abnormalities of depression and PTSD, the neuroendocrine abnormalities observed are much different, and thus, different modes and targeted treatments are necessary.

In those with unmanaged stresses, it is essential to (1) make an accurate diagnosis earliest possible, (2) establish a network of support and (3) provide focused multimodal, individualized treatments to maximize the recovery process and prevent relapses. However, because of the underlying hormonal abnormalities, psychotherapy and psychiatric medications alone may not be adequate to cure PTSD. Thus, adjunct therapy, with treatments based on understanding the pathobiology and alterations of the neurohormonal systems, together with non-traditional approaches such as mindful meditation methods, as cost-effective.[Citation5] Current evidence indicates PTSD is not only a psychological disorder but also a chronic medical illness resulting from endocrine pathology.[Citation26]

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

References

  • Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29(5):567–592.
  • Wimalawansa SJ. Causes and risk factors for posttraumatic stress disorder: the importance of right diagnosis and treatment. Asian J Med Sci. 2013;5(2):29–40.
  • Flory JD, Yehuda R. Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin Neurosci. 2015;17(2):141–150.
  • Mavroveli S, Sanchez-Ruiz MJ. Trait emotional intelligence influences on academic achievement and school behaviour. Br J Educ Psychol. 2011;81(Pt 1):112–134.
  • Wimalawansa SJ. Post-traumatic stress disorder: an under-diagnosed and under-treated entity. Compr Res J Med Med Sci. 2013;1:12.
  • Wimalawansa SJ. Mechanisms of developing post-traumatic stress disorder: new targets for drug development and other potential interventions. CNS Neurol Disord Drug Targets. 2014;13(5):807–816.
  • Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annu Rev Physiol. 2005;67:259–284.
  • Gold PW, et al. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann N Y Acad Sci. 1995;771:716–729.
  • Copstead L-EB. Jacquelyn. In Pathophysiology, 5th edn. 2013; St Louis, Missouri: Elsevier Saunders.
  • McEwen BSS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43(1):2–15.
  • van Zuiden M, Kavelaars A, Geuze E, et al. Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions. Brain Behav Immun. 2012;30;12–21.
  • Wingenfeld K, et al. Effects of cortisol on memory in women with borderline personality disorder: role of co-morbid post-traumatic stress disorder and major depression. Psychol Med. 2013;43(3):495–505.
  • Lang AJ, et al. The theoretical and empirical basis for meditation as an intervention for PTSD. Behav Modif. 2012;36(6):759–786.
  • Wimalawansa SJ. Meditation for everyone: a guide to personal happiness. 2012; ISBN: 978-955-458400-6. Homagama, Sri Lanka: Karunaratne & Sons.
  • Jovanovic T, et al. Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology. 2012;62(2):695–704.
  • Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians. 1999;111(1):22–34.
  • Zohar J, et al. Post-traumatic stress disorder: facts and fiction. Curr Opin Psychiatry. 2008;21(1):74–77.
  • Farhood LF, Dimassi H. Prevalence and predictors for post-traumatic stress disorder, depression and general health in a population from six villages in South Lebanon. Soc Psychiatry Psychiatr Epidemiol. 2012;47(4):639–649.
  • Chapman C, et al. Remission from post-traumatic stress disorder in the general population. Psychol Med. 2012;42(8):1695–1703.
  • Delimar D, et al. The effect of different traumatic experiences on the development of post-traumatic stress disorder. Mil Med. 1995;160(12):635–639.
  • Golier J, Yehuda R. Neuropsychological processes in post-traumatic stress disorder. Psychiatr Clin North Am. 2002;25(2):295–315, vi.
  • Skelton K, et al. PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 2012;62(2):628–637.
  • Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374–381.
  • Ortega J, et al. Predictors of psychological symptoms in morbidly obese patients after gastric bypass surgery. Surg Obes Relat Dis. 2012;8(6):770–776.
  • Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25(1):1–35.
  • Yehuda R. Post-traumatic stress disorder. N Engl J Med. 2002;346(2):108–114.
  • Wingenfeld K, et al. Cortisol effects on autobiographic memory retrieval in PTSD: an analysis of word valence and time until retrieval. Stress. 2013;16(5):581–586.
  • Elenkov IJ, et al. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci. 1999;876:1-11; discussion 11-3.
  • McFarlane AC, Yehuda R, Clark CR. Biologic models of traumatic memories and post-traumatic stress disorder. The role of neural networks. Psychiatr Clin North Am. 2002;25(2):253–270.
  • Boscarino JA. Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J Consult Clin Psychol. 1996;64(1):191–201.
  • Bremner JD, et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry. 2003;160(5):924–932.
  • Chrousos GP, Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress. 2007;10(2):213–219.
  • Yehuda R, et al. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 1996;40(2):79–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.